BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Xcelience Set to Double Staff as New Plant Opens


9/12/2012 8:07:55 AM

Xcelience LLC expects to hire its 100th worker, as it prepares to open a new facility in Tampa.

The company, which contracts with pharmaceutical firms to formulate and analyze drugs in development, will open the 24,000-square-foot plant at 4901 Grace St., south of Tampa International Airport, on Sept. 14. It’s the company’s second facility in the Tampa Bay area, and will enable the company to double headcount over the next three years, a statement said.

The new jobs made the company eligible for a Florida Qualified Targeted Industry tax refund incentive award of $135,000, according to an announcement when the project initially was announced a little over a year ago. Representatives of the Tampa Hillsborough Economic Development Corp. and the Tampa Bay Partnership are scheduled to attend the opening, as are Mayor Bob Buckhorn, Hillsborough County Commissioner Al Higginbotham, and Rep. Donna Young.

The new building will be used for primary and secondary packaging, labeling, distribution and warehouse services, and it will audited and approved for domestic as well as European clinical trials.




Xcelience
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES